Skip to main content
رجوع
HGYMF logo

Hogy Medical Co.,Ltd.

جودة البيانات: 100%
ذروة شراء
HGYMF
OTC Healthcare Medical - Instruments & Supplies
KWD 34.99
KWD 0.00 (0.00%)
القيمة السوقية: 754.38M
نطاق اليوم
KWD 34.99 KWD 35.03
نطاق 52 أسبوعًا
KWD 24.34 KWD 35.51
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 34.99 / KWD 30.86
الإغلاق السابق
KWD 34.99

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 0.5 0.4
P/B 0.0 2.9
ROE % 1.9 3.8
Net Margin % 3.9 3.9
Rev Growth 5Y % 1.8 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.607
KWD 1.607 – KWD 1.607
 43 B 1
FY2029 KWD 1.083
KWD 1.083 – KWD 1.083
 42 B 1
FY2028 KWD 0.964
KWD 0.964 – KWD 0.964
 39 B 1

النقاط الرئيسية

Revenue grew 1.76% annually over 5 years — modest growth
Earnings declined -45.79% over the past year
ROE of 1.89% is below average
Debt/Equity of 0.19 — conservative balance sheet
Generating 6.25B in free cash flow
P/E of 0.50 — trading at a low valuation

النمو

Revenue Growth (5Y)
1.76%
Revenue (1Y)0.10%
Earnings (1Y)-45.79%
FCF Growth (3Y)926.74%

الجودة

Return on Equity
1.89%
ROIC3.24%
Net Margin3.88%
Op. Margin9.73%

الأمان

Debt / Equity
0.19
Current Ratio4.26
Interest Coverage54.43

التقييم

P/E Ratio
0.50
P/B Ratio0.01
EV/EBITDA-1.96
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 0.10% Revenue Growth (3Y) 0.20%
Earnings Growth (1Y) -45.79% Earnings Growth (3Y) -40.66%
Revenue Growth (5Y) 1.76% Earnings Growth (5Y) -25.59%
Profitability
Revenue (TTM) 39.14B Net Income (TTM) 1.52B
ROE 1.89% ROA 1.55%
Gross Margin 32.25% Operating Margin 9.73%
Net Margin 3.88% Free Cash Flow (TTM) 6.25B
ROIC 3.24% FCF Growth (3Y) 926.74%
Safety
Debt / Equity 0.19 Current Ratio 4.26
Interest Coverage 54.43 Dividend Yield 0.02%
Valuation
P/E Ratio 0.50 P/B Ratio 0.01
P/S Ratio 0.02 PEG Ratio -1.30
EV/EBITDA -1.96 Dividend Yield 0.02%
Market Cap 754.38M Enterprise Value -7.46B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 39.14B 39.10B 38.98B 302.13M 36.50B
Net Income 1.52B 2.80B 4.32B 4.37B 4.96B
EPS (Diluted) 67.98 115.54 177.95 153.00 164.03
Gross Profit 12.62B 13.06B 113.44M 120.04M 130.51M
Operating Income 3.81B 4.17B 6.63B 6.14B 5.63B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97.90B 100.04B 769.11M 813.01M 956.05M
Total Liabilities 23.56B 13.92B 139.24M 155.82M 87.70M
Shareholders' Equity 74.32B 86.11B 83.61B 79.96B 95.88B
Total Debt 13.79B 5.82B 8.89B 10.00B 330.00M
Cash & Equivalents 22.01B 19.42B 138.14M 113.53M 180.19M
Current Assets 44.20B 43.03B 40.29B 35.29B 41.32B
Current Liabilities 10.38B 8.24B 11.13B 9.35B 7.59B

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#158 of 820
59
Value Defensive Investing (Benjamin Graham)
#339 of 708
29

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026